| Literature DB >> 26111172 |
Jia-Zhong Cai1,2, Rong Tang3, Gui-Fu Ye4, Sheng-Xiang Qiu5, Nen-Ling Zhang6, Ying-Jie Hu7, Xiao-Ling Shen8.
Abstract
A new natural halogen-containing stilbene derivative was isolated from the leaves of Cajanus cajan (L.) Millsp. and identified as 3-O-(3-chloro-2-hydroxyl-propanyl)-longistylin A by comprehensive spectroscopic and chemical analysis, and named cajanstilbene H (1). It is the first halogen-containing stilbene derivative found from plants. In human mesenchymal stem cells (hMSC) from bone marrow, 1 did not promote cell proliferation, but distinctly enhanced osteogenic differentiation of hMSC in time- and dose-dependent manners. In six human cancer cell lines, 1 showed a moderate inhibitory effect on cell proliferation, with IC50 values of 21.42-25.85 μmol·L(-1).Entities:
Keywords: Cajanus cajan (L.) Millsp.; cajanstilbene H; halogen; human mesenchymal stem cells; osteogenic diffrentiation; stilbene
Mesh:
Substances:
Year: 2015 PMID: 26111172 PMCID: PMC6272782 DOI: 10.3390/molecules200610839
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
1H- and 13C-NMR data of 1 in CDCl3.
| Position | Cajanstilbene H (1) | ||
|---|---|---|---|
| δC a, type | δH
b ( | HMBC c | |
| 1 | 136.4 s | 7, 8 | |
| 2 | 103.0 d | 6.68 s | 6, 7, 8 |
| 3 | 156.8 s | 6 | |
| 4 | 118.3 s | 2, 6 | |
| 5 | 158.2 s | 2, OMe | |
| 6 | 102.9 d | 6.71 s | 2, 7, 8 |
| 7 | 128.8 d | 7.04 s | 2, 6, 2′, 3′, 5′, 6′ |
| 8 | 128.8 d | 7.04 s | 2, 6, 2′, 3′, 5′, 6′ |
| 1′ | 137.2 s | 7, 8, 3′, 5′ | |
| 2′, 6′ | 126.6 d | 7.50 d (7.5) | 7, 8, 2′, 4′, 6′ |
| 3′, 5′ | 128.7 d | 7.35 t (7.5) | 2′, 3′, 5′, 6′ |
| 4′ | 127.7 d | 7.24 m | 2′, 6′ |
| 1″ | 22.4 t | 3.34 d (6.8) | |
| 2″ | 123.2 d | 5.11 t (6.8) | |
| 3″ | 131.5 s | 4′′, 5′′ | |
| 4″ | 25.7 q | 1.66 s | 2′′ |
| 5″ | 17.9 q | 1.79 s | 2′′ |
| 5-OMe | 55.8 q | 3.86 s | |
| 3-OH | |||
| 1′′′ | 68.9 t | 4.14 m | 3′′′ |
| 2′′′ | 70.0 t | 4.21 m | 1′′′, 3′′′ |
| 3′′′ | 45.8 t | 3.75 m | 1′′′ |
| 2′′′-OH | 2.70 s | ||
a Measured at 400 MHz. b Measured at 100 MHz. c HMBC corrections: H to C. Assignments were supported with HSQC and HMBC spectra.
Figure 1Structure (A) and Key HMBC correlations (B) of cajanstilbene H (1).
Figure 2The 48 h proliferation assay for compound 1 in human mesenchymal stem cells (hMSC). Cell viability was measured using Cell Conuting Kit 8. Data were expressed as Mean ± SD (n = 3).
Figure 3Detection of extracellular calcium deposits and membrane alkaline phosphatase (AP) activity in differentiated osteoblasts. Alizarin red S staining after inducing for osteogenic differentiation for 14 days (A) and 17 days (B) showed time and dose-dependent increases in calcium deposits (red color) in hMSC treated with compound 1, indicating enhanced osteoblast formation. 5-Bromo-4-chloro-3-indolyl phosphate/Nitro blue tetrazolium (BCIP/NBT) staining (cell AP activity staining kit) ((C) 14 days; (D) 17 days) exhibited much more blue-violet color in hMSC treated with 1 than that in control or cells treated with 0.16% DMSO, inferring elevated cellular AP activity in osteoblasts.
IC50 values (μM) of 1 in six human cancer cell lines at 48 h. Cancer cells were treated with Cajanstilbene H (1) or paclitaxel (positive control) for 48 h. Cell viability was measured by MTT assay. Data were expressed as Mean ± SD of three independent experiments.
| NCI-H460 | PC-3 | MCF-7 | HeLa | HCT-15 | KB-V1 | |
|---|---|---|---|---|---|---|
| 21.47 ± 3.14 | 25.83 ± 3.64 | 21.42 ± 3.31 | 25.85 ± 2.58 | 24.81 ± 5.20 | 22.29 ± 6.39 | |
| Paclitaxel | 0.036 ± 0.004 | 0.048 ± 0.013 | 0.032 ± 0.004 | 0.072 ± 0.018 | 0.021 ± 0.003 | 0.225 ± 0.059 |